Ovarian cancer, Surgery, Internal medicine, Cancer and Stage are his primary areas of study. His Ovarian cancer research incorporates themes from Cancer research, Immunology, Intensive care medicine, Disease and Improved survival. His studies in Surgery integrate themes in fields like Debulking, Cohort and General surgery.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology. The various areas that Robert E. Bristow examines in his Cancer study include Salvage therapy and Pathology. His Stage research incorporates elements of Gynecologic oncology, Carcinoma, Retrospective cohort study and Urology.
Robert E. Bristow mainly focuses on Internal medicine, Ovarian cancer, Surgery, Oncology and Cancer. Obstetrics, Endometrial cancer and Cervical cancer is closely connected to Gynecology in his research, which is encompassed under the umbrella topic of Internal medicine. His Ovarian cancer study combines topics in areas such as Gynecologic oncology, Guideline and General surgery.
His studies deal with areas such as Cytoreductive surgery and Logistic regression as well as Surgery. His biological study spans a wide range of topics, including Prostate cancer and Epithelial ovarian cancer. Many of his studies on Cancer involve topics that are commonly interrelated, such as Odds ratio.
His scientific interests lie mostly in Internal medicine, Ovarian cancer, Oncology, Cancer and Surgery. His research investigates the connection with Internal medicine and areas like Gynecology which intersect with concerns in Referral. Robert E. Bristow has included themes like Young adult, Physical therapy and Intensive care medicine in his Ovarian cancer study.
He focuses mostly in the field of Oncology, narrowing it down to matters related to Stage and, in some cases, Cervical cancer and Perioperative. Robert E. Bristow combines subjects such as Guideline, Guideline adherence, Retrospective cohort study and Standard treatment with his study of Cancer. His study in Surgery is interdisciplinary in nature, drawing from both Cytoreductive surgery and Sarcoma.
Ovarian cancer, Surgery, Cancer, Internal medicine and Guideline are his primary areas of study. He interconnects Young adult and Abdomen in the investigation of issues within Ovarian cancer. His research on Surgery frequently connects to adjacent areas such as Cardiophrenic Lymph Node.
His Cancer research incorporates themes from Intervention, Physical therapy, Standard treatment and Emergency medicine. His Internal medicine research is multidisciplinary, relying on both Gynecology and Oncology. His Oncology study integrates concerns from other disciplines, such as Randomized controlled trial and General surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
Robert E. Bristow;Rafael S. Tomacruz;Deborah K. Armstrong;Edward L. Trimble.
Journal of Clinical Oncology (2002)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Dennis S. Chi;Eric L. Eisenhauer;Oliver Zivanovic;Yukio Sonoda.
Gynecologic Oncology (2009)
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
Craig C. Earle;Deborah Schrag;Bridget A. Neville;K. Robin Yabroff.
Journal of the National Cancer Institute (2006)
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
Robert E. Bristow;Dennis S. Chi.
Gynecologic Oncology (2006)
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Robert E. Bristow;Isha Puri;Dennis S. Chi.
Gynecologic Oncology (2009)
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Robert E. Bristow;Fredrick J. Montz;Leo D. Lagasse;Ronald S. Leuchter.
Gynecologic Oncology (1999)
A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
Robert E. Bristow;Linda R. Duska;Nicholas C. Lambrou;Elliot K. Fishman.
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Camille C. Gunderson;Amanda Nickles Fader;Amanda Nickles Fader;Kathryn A. Carson;Robert E. Bristow.
Gynecologic Oncology (2012)
Increased Plasma DNA Integrity in Cancer Patients
Brant G. Wang;Han Yao Huang;Yu Chi Chen;Robert E. Bristow.
Cancer Research (2003)
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
Ritu Salani;Floor J. Backes;Michael Fung Kee Fung;Christine H. Holschneider.
American Journal of Obstetrics and Gynecology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: